Cargando…

Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma

Lung cancer is a major cause of cancer-related deaths globally, with a dismal prognosis. N7-methylguanosine (m7G) is essential for the transcriptional phenotypic modification of messenger RNA (mRNA) and long noncoding RNA (lncRNA). However, research on m7G-related lncRNAs involved in lung adenocarci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chuanhao, Zhou, Dong, Wang, Zhe, Ju, Zaishuang, He, Jiabei, Zhao, Genghao, Wang, Ruoyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214213/ https://www.ncbi.nlm.nih.gov/pubmed/35754819 http://dx.doi.org/10.3389/fgene.2022.907754

Ejemplares similares

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2022)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022)

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma
por: Fang, Xueying, et al.
Publicado: (2022)

Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma
por: Lu, Jiawei, et al.
Publicado: (2023)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

M(7)G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma
por: Wu, Shuaishuai, et al.
Publicado: (2022)

Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients
por: Luo, Ting, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
por: Luo, Jian, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
por: Luo, Lianghua, et al.
Publicado: (2022)

A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma
por: Ding, Wencong, et al.
Publicado: (2022)

An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism
por: Liang, Jiali, et al.
Publicado: (2022)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer
por: Li, Zhenchi, et al.
Publicado: (2023)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma
por: Rong, Jielin, et al.
Publicado: (2022)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

A novel m7G methylation–related signature associated with chromosome homeostasis in patients with lung adenocarcinoma
por: Tao, Xiaoying, et al.
Publicado: (2022)

Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma
por: Tong, Fang, et al.
Publicado: (2022)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
por: Ren, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kmq76m3godf3fg92158kvlcpv6